Oral GLP-1 weight loss pills could replace injections by March 2026 at $150 monthly, Medicare chief Dr. Mehmet Oz predicted ...

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The ...

Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up ...

The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...

Experts say the deal to lower the cost of the drugs is ambitious, but left some with more questions than answers.

The Trump administration announced a deal with Eli Lilly and Novo Nordisk to lower the costs of GLP-1 medications, which may ...

A NEW weight loss drug may offer a tempting alternative to popular GLP-1 drugs like Ozempic and Wegovy. The once-weekly ...

Dr. Oz estimated Americans could lose "135 billion pounds" by the midterm elections next year. The administrator of the ...

The monthly out-of-pocket cost of popular injections and upcoming pills could range from $50 to $350, depending on the dosage ...

Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...

Poviztra (semaglutide injection 2.4 mg) is the second brand of Wegovy, Novo Nordisk’s blockbuster obesity medication, which ...